Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 21538434)

1.

Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men.

Lai JC, Verna EC, Brown RS Jr, O'Leary JG, Trotter JF, Forman LM, Duman JD, Foster RG, Stravitz RT, Terrault NA; Consortium to Study Health Outcomes in HCV Liver Transplant Recipients (CRUSH-C).

Hepatology. 2011 Aug;54(2):418-24. doi: 10.1002/hep.24390. Epub 2011 Jun 23.

2.

Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C.

Saxena V, Lai JC, O'Leary JG, Verna EC, Brown RS Jr, Stravitz RT, Trotter JF, Krishnan K, Terrault NA; Consortium to Study Health Outcomes in HCV Liver Transplant Recipients.

Liver Transpl. 2012 May;18(5):524-31. doi: 10.1002/lt.22461.

3.

Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.

Terrault NA, Stravitz RT, Lok AS, Everson GT, Brown RS Jr, Kulik LM, Olthoff KM, Saab S, Adeyi O, Argo CK, Everhart JE, Rodrigo del R; A2ALL Study Group.

Hepatology. 2014 Apr;59(4):1311-9. doi: 10.1002/hep.26920. Epub 2014 Mar 1.

4.

Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.

Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Schmidt WN.

Transplantation. 2007 Aug 15;84(3):331-9.

PMID:
17700157
5.

Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.

Taner CB, Bulatao IG, Keaveny AP, Willingham DL, Pungpapong S, Perry DK, Rosser BG, Harnois DM, Aranda-Michel J, Nguyen JH.

Liver Transpl. 2011 Jun;17(6):641-9. doi: 10.1002/lt.22258.

6.

Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus.

Brandman D, Pingitore A, Lai JC, Roberts JP, Ferrell L, Bass NM, Terrault NA.

Liver Transpl. 2011 Dec;17(12):1380-6. doi: 10.1002/lt.22389.

7.

Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: model to predict HCV cirrhosis after liver transplantation.

Iacob S, Cicinnati VR, Hilgard P, Iacob RA, Gheorghe LS, Popescu I, Frilling A, Malago M, Gerken G, Broelsch CE, Beckebaum S.

Transplantation. 2007 Jul 15;84(1):56-63.

PMID:
17627238
8.

Explanted liver inflammatory grade predicts fibrosis progression in hepatitis C recurrence.

Ghabril M, Dickson RC, Krishna M, Machicao V, Aranda-Michel J, Bonatti H, Nguyen JH.

Liver Transpl. 2011 Jun;17(6):685-94. doi: 10.1002/lt.22250.

9.

Long-term outcome of hepatitis C infection after liver transplantation.

Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R.

N Engl J Med. 1996 Mar 28;334(13):815-20.

10.

Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study.

Lai JC, O'Leary JG, Trotter JF, Verna EC, Brown RS Jr, Stravitz RT, Duman JD, Forman LM, Terrault NA; Consortium to Study Health Outcomes in HCV Liver Transplant Recipients (CRUSH-C).

Liver Transpl. 2012 May;18(5):532-8. doi: 10.1002/lt.23396.

11.

Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus.

Verna EC, Valadao R, Farrand E, Pichardo EM, Lai JC, Terrault NA, Brown RS Jr.

Liver Transpl. 2012 Apr;18(4):461-7. doi: 10.1002/lt.23376.

12.
13.

Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.

Terrault NA, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, Ragni MV, Barin B, Simon D, Olthoff KM, Johnson L, Stosor V, Jayaweera D, Fung J, Sherman KE, Subramanian A, Millis JM, Slakey D, Berg CL, Carlson L, Ferrell L, Stablein DM, Odim J, Fox L, Stock PG; Solid Organ Transplantation in HIV: Multi-Site Study Investigators.

Liver Transpl. 2012 Jun;18(6):716-26. doi: 10.1002/lt.23411.

14.

Predisposing factors of diminished survival in simultaneous liver/kidney transplantation.

Hibi T, Sageshima J, Molina E, Ciancio G, Nishida S, Chen L, Arosemena L, Mattiazzi A, Guerra G, Kupin W, Tekin A, Selvaggi G, Levi D, Ruiz P, Livingstone AS, Roth D, Martin P, Tzakis A, Burke GW.

Am J Transplant. 2012 Nov;12(11):2966-73. doi: 10.1111/j.1600-6143.2012.04121.x. Epub 2012 Jun 8.

15.

Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.

Waki K, Sugawara Y, Tamura S, Mieno MN, Yamashiki N, Kadowaki T, Kokudo N.

Transplantation. 2011 Oct 15;92(7):809-14. doi: 10.1097/TP.0b013e31822d4dc3.

PMID:
21832961
16.

Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.

Tao R, Ruppert K, Cruz RJ Jr, Malik SM, Shaikh O, Ahmad J, DiMartini A, Humar A, Fontes PA, de Vera ME.

Liver Transpl. 2010 Nov;16(11):1288-95. doi: 10.1002/lt.22168.

17.

Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.

Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR.

Liver Transpl. 2002 Apr;8(4):362-9.

18.

Donor Risk Index for African American liver transplant recipients with hepatitis C virus.

Shores NJ, Dodge JL, Feng S, Terrault NA.

Hepatology. 2013 Oct;58(4):1263-9. doi: 10.1002/hep.26478. Epub 2013 Aug 6.

PMID:
23696235
19.

Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.

Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G.

Liver Transpl. 2007 May;13(5):733-40.

20.

One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.

Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Cabrera R, Shuster JJ, Theriaque D, Reed AI, Hemming AW, Liu C, Crawford JM, Nelson DR.

Liver Transpl. 2004 Oct;10(10):1240-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk